United States Hepatitis Drugs Market Report 2017

January 2017 | 106 pages | ID: UB79AD0EFDFEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Hepatitis Drugs

Revenue, means the sales value of Hepatitis Drugs

This report studies sales (consumption) of Hepatitis Drugs in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• F. Hoffmann-La Roche
• Gilead Sciences
• GlaxoSmithKline
• Johnson & Johnson
• Merck
• Novartis
• Vertex Pharmaceuticals
• Abbvie
• Achillion Pharmaceuticals
• Bristol-Myers Squibb
• Dynavax Technologies
• Mitsubishi Tanabe Pharma

Market Segment by States, covering

• California
• Texas
• New York
• Florida
• Illinois

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Oral
• Injection

Split by applications, this report focuses on sales, market share and growth rate of Hepatitis Drugs in each application, can be divided into

• Hospital
• Clinic

Contents

United States Hepatitis Drugs Market Report 2017

1 HEPATITIS DRUGS OVERVIEW

1.1 Product Overview and Scope of Hepatitis Drugs
1.2 Classification of Hepatitis Drugs
  1.2.1 Oral
  1.2.2 Injection
1.3 Application of Hepatitis Drugs
  1.3.1 Hospital
  1.3.2 Clinic
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Hepatitis Drugs (2011-2021)
  1.4.1 United States Hepatitis Drugs Sales and Growth Rate (2011-2021)
  1.4.2 United States Hepatitis Drugs Revenue and Growth Rate (2011-2021)

2 UNITED STATES HEPATITIS DRUGS COMPETITION BY MANUFACTURERS

2.1 United States Hepatitis Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Hepatitis Drugs Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Hepatitis Drugs Average Price by Manufactures (2015 and 2016)
2.4 Hepatitis Drugs Market Competitive Situation and Trends
  2.4.1 Hepatitis Drugs Market Concentration Rate
  2.4.2 Hepatitis Drugs Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES HEPATITIS DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY STATES (2011-2016)

3.1 United States Hepatitis Drugs Sales and Market Share by States (2011-2016)
3.2 United States Hepatitis Drugs Revenue and Market Share by States (2011-2016)
3.3 United States Hepatitis Drugs Price by States (2011-2016)

4 UNITED STATES HEPATITIS DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

4.1 United States Hepatitis Drugs Sales and Market Share by Type (2011-2016)
4.2 United States Hepatitis Drugs Revenue and Market Share by Type (2011-2016)
4.3 United States Hepatitis Drugs Price by Type (2011-2016)
4.4 United States Hepatitis Drugs Sales Growth Rate by Type (2011-2016)

5 UNITED STATES HEPATITIS DRUGS SALES (VOLUME) BY APPLICATION (2011-2016)

5.1 United States Hepatitis Drugs Sales and Market Share by Application (2011-2016)
5.2 United States Hepatitis Drugs Sales Growth Rate by Application (2011-2016)
5.3 Market Drivers and Opportunities

6 UNITED STATES HEPATITIS DRUGS MANUFACTURERS PROFILES/ANALYSIS

6.1 F. Hoffmann-La Roche
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Hepatitis Drugs Product Type, Application and Specification
    6.1.2.1 Oral
    6.1.2.2 Injection
  6.1.3 F. Hoffmann-La Roche Hepatitis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.1.4 Main Business/Business Overview
6.2 Gilead Sciences
  6.2.2 Hepatitis Drugs Product Type, Application and Specification
    6.2.2.1 Oral
    6.2.2.2 Injection
  6.2.3 Gilead Sciences Hepatitis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.2.4 Main Business/Business Overview
6.3 GlaxoSmithKline
  6.3.2 Hepatitis Drugs Product Type, Application and Specification
    6.3.2.1 Oral
    6.3.2.2 Injection
  6.3.3 GlaxoSmithKline Hepatitis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.3.4 Main Business/Business Overview
6.4 Johnson & Johnson
  6.4.2 Hepatitis Drugs Product Type, Application and Specification
    6.4.2.1 Oral
    6.4.2.2 Injection
  6.4.3 Johnson & Johnson Hepatitis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.4.4 Main Business/Business Overview
6.5 Merck
  6.5.2 Hepatitis Drugs Product Type, Application and Specification
    6.5.2.1 Oral
    6.5.2.2 Injection
  6.5.3 Merck Hepatitis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.5.4 Main Business/Business Overview
6.6 Novartis
  6.6.2 Hepatitis Drugs Product Type, Application and Specification
    6.6.2.1 Oral
    6.6.2.2 Injection
  6.6.3 Novartis Hepatitis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.6.4 Main Business/Business Overview
6.7 Vertex Pharmaceuticals
  6.7.2 Hepatitis Drugs Product Type, Application and Specification
    6.7.2.1 Oral
    6.7.2.2 Injection
  6.7.3 Vertex Pharmaceuticals Hepatitis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.7.4 Main Business/Business Overview
6.8 Abbvie
  6.8.2 Hepatitis Drugs Product Type, Application and Specification
    6.8.2.1 Oral
    6.8.2.2 Injection
  6.8.3 Abbvie Hepatitis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.8.4 Main Business/Business Overview
6.9 Achillion Pharmaceuticals
  6.9.2 Hepatitis Drugs Product Type, Application and Specification
    6.9.2.1 Oral
    6.9.2.2 Injection
  6.9.3 Achillion Pharmaceuticals Hepatitis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.9.4 Main Business/Business Overview
6.10 Bristol-Myers Squibb
  6.10.2 Hepatitis Drugs Product Type, Application and Specification
    6.10.2.1 Oral
    6.10.2.2 Injection
  6.10.3 Bristol-Myers Squibb Hepatitis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.10.4 Main Business/Business Overview
6.11 Dynavax Technologies
6.12 Mitsubishi Tanabe Pharma

7 HEPATITIS DRUGS MANUFACTURING COST ANALYSIS

7.1 Hepatitis Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Hepatitis Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Hepatitis Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Hepatitis Drugs Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES HEPATITIS DRUGS MARKET FORECAST (2016-2021)

11.1 United States Hepatitis Drugs Sales, Revenue Forecast (2016-2021)
11.2 United States Hepatitis Drugs Sales Forecast by Type (2016-2021)
11.3 United States Hepatitis Drugs Sales Forecast by Application (2016-2021)
11.4 Hepatitis Drugs Price Forecast (2016-2021)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Hepatitis Drugs
Table Classification of Hepatitis Drugs
Figure United States Sales Market Share of Hepatitis Drugs by Type in 2015
Figure Oral Picture
Figure Injection Picture
Table Application of Hepatitis Drugs
Figure United States Sales Market Share of Hepatitis Drugs by Application in 2015
Figure Hospital Examples
Figure Clinic Examples
Figure United States Hepatitis Drugs Sales and Growth Rate (2011-2021)
Figure United States Hepatitis Drugs Revenue and Growth Rate (2011-2021)
Table United States Hepatitis Drugs Sales of Key Manufacturers (2015 and 2016)
Table United States Hepatitis Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Hepatitis Drugs Sales Share by Manufacturers
Figure 2016 Hepatitis Drugs Sales Share by Manufacturers
Table United States Hepatitis Drugs Revenue by Manufacturers (2015 and 2016)
Table United States Hepatitis Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Hepatitis Drugs Revenue Share by Manufacturers
Table 2016 United States Hepatitis Drugs Revenue Share by Manufacturers
Table United States Market Hepatitis Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Hepatitis Drugs Average Price of Key Manufacturers in 2015
Figure Hepatitis Drugs Market Share of Top 3 Manufacturers
Figure Hepatitis Drugs Market Share of Top 5 Manufacturers
Table United States Hepatitis Drugs Sales by States (2011-2016)
Table United States Hepatitis Drugs Sales Share by States (2011-2016)
Figure United States Hepatitis Drugs Sales Market Share by States in 2015
Table United States Hepatitis Drugs Revenue and Market Share by States (2011-2016)
Table United States Hepatitis Drugs Revenue Share by States (2011-2016)
Figure Revenue Market Share of Hepatitis Drugs by States (2011-2016)
Table United States Hepatitis Drugs Price by States (2011-2016)
Table United States Hepatitis Drugs Sales by Type (2011-2016)
Table United States Hepatitis Drugs Sales Share by Type (2011-2016)
Figure United States Hepatitis Drugs Sales Market Share by Type in 2015
Table United States Hepatitis Drugs Revenue and Market Share by Type (2011-2016)
Table United States Hepatitis Drugs Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Hepatitis Drugs by Type (2011-2016)
Table United States Hepatitis Drugs Price by Type (2011-2016)
Figure United States Hepatitis Drugs Sales Growth Rate by Type (2011-2016)
Table United States Hepatitis Drugs Sales by Application (2011-2016)
Table United States Hepatitis Drugs Sales Market Share by Application (2011-2016)
Figure United States Hepatitis Drugs Sales Market Share by Application in 2015
Table United States Hepatitis Drugs Sales Growth Rate by Application (2011-2016)
Figure United States Hepatitis Drugs Sales Growth Rate by Application (2011-2016)
Table F. Hoffmann-La Roche Basic Information List
Table F. Hoffmann-La Roche Hepatitis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure F. Hoffmann-La Roche Hepatitis Drugs Sales Market Share (2011-2016)
Table Gilead Sciences Basic Information List
Table Gilead Sciences Hepatitis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Gilead Sciences Hepatitis Drugs Sales Market Share (2011-2016)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Hepatitis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Hepatitis Drugs Sales Market Share (2011-2016)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Hepatitis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Johnson & Johnson Hepatitis Drugs Sales Market Share (2011-2016)
Table Merck Basic Information List
Table Merck Hepatitis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck Hepatitis Drugs Sales Market Share (2011-2016)
Table Novartis Basic Information List
Table Novartis Hepatitis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis Hepatitis Drugs Sales Market Share (2011-2016)
Table Vertex Pharmaceuticals Basic Information List
Table Vertex Pharmaceuticals Hepatitis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Vertex Pharmaceuticals Hepatitis Drugs Sales Market Share (2011-2016)
Table Abbvie Basic Information List
Table Abbvie Hepatitis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Abbvie Hepatitis Drugs Sales Market Share (2011-2016)
Table Achillion Pharmaceuticals Basic Information List
Table Achillion Pharmaceuticals Hepatitis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Achillion Pharmaceuticals Hepatitis Drugs Sales Market Share (2011-2016)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Hepatitis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bristol-Myers Squibb Hepatitis Drugs Sales Market Share (2011-2016)
Table Dynavax Technologies Basic Information List
Table Mitsubishi Tanabe Pharma Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Hepatitis Drugs
Figure Manufacturing Process Analysis of Hepatitis Drugs
Figure Hepatitis Drugs Industrial Chain Analysis
Table Raw Materials Sources of Hepatitis Drugs Major Manufacturers in 2015
Table Major Buyers of Hepatitis Drugs
Table Distributors/Traders List
Figure United States Hepatitis Drugs Production and Growth Rate Forecast (2016-2021)
Figure United States Hepatitis Drugs Revenue and Growth Rate Forecast (2016-2021)
Table United States Hepatitis Drugs Production Forecast by Type (2016-2021)
Table United States Hepatitis Drugs Consumption Forecast by Application (2016-2021)
Table United States Hepatitis Drugs Sales Forecast by States (2016-2021)
Table United States Hepatitis Drugs Sales Share Forecast by States (2016-2021)